DrugPatentWatch Database Preview
Mechanism of Action: HIV Protease Inhibitors
» See Plans and Pricing
Drugs with Mechanism of Action: HIV Protease Inhibitors
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim | APTIVUS | tipranavir | SOLUTION;ORAL | 022292-001 | Jun 23, 2008 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Boehringer Ingelheim | APTIVUS | tipranavir | CAPSULE;ORAL | 021814-001 | Jun 22, 2005 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Cipla | ATAZANAVIR SULFATE | atazanavir sulfate | CAPSULE;ORAL | 200626-004 | Aug 9, 2018 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Aurobindo Pharma Ltd | ATAZANAVIR SULFATE | atazanavir sulfate | CAPSULE;ORAL | 204806-004 | Jun 25, 2018 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Teva Pharms Usa | ATAZANAVIR SULFATE | atazanavir sulfate | CAPSULE;ORAL | 091673-004 | Apr 22, 2014 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Amneal | ATAZANAVIR SULFATE | atazanavir sulfate | CAPSULE;ORAL | 209717-001 | Jun 1, 2020 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
